Skip to search formSkip to main contentSkip to account menu

AK 295

Known as: AK-295, AK295, Carbamic acid, (1-(((1-ethyl-3-((3-(4-morpholinyl)propyl)amino)-2,3-dioxopropyl)amino)carbonyl)-3-methylbutyl)-, phenylmethyl ester, stereoisomer 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Objectives: In the present investigation, the effect of a calpain inhibitor, AK 295, on ischemia/ reperfusion damage in rat… 
2011
2011
Frequently, noise-induced hearing loss is associated with the symptom of tinnitus. Preliminary results in the animal model after… 
2010
2010
e13510 Background: Paclitaxel is a chemotherapeutic agent that induces apoptosis of tumor cells in several cancer types including… 
2009
2009
Guillain-Barre syndrome (GBS) is a peripheral neuropathy characterised by acute flaccid paralysis. The axonal variant is… 
Highly Cited
2000
Highly Cited
2000
Administration of the selective calpain inhibitor AK295 has been shown to attenuate motor and cognitive dysfunction after brain… 
2000
2000
Purpose. To compare effects of calpain inhibitors on in vitro light-scattering in rat lens soluble protein and calcium-ionophore… 
1998
1998
We have determined the effects of the calpain inhibitors AK275 and AK295 upon purified m‐calpain and calcium‐mediated degradation… 
1998
1998
Frequently, noise-induced hearing loss is associated with the symptom of tinnitus. Preliminary results in the animal model after…